Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19
暂无分享,去创建一个
C. A. Shaw | C. Sudlow | A. Sheikh | I. Buchan | P. Horby | C. Gamble | J. Scott-Brown | J. Baillie | C. Jackson | M. van Smeden | J. Nguyen-Van-Tam | I. Abubakar | P. Olliaro | M. Noursadeghi | L. Merson | T. Solomon | J. Dunning | P. Openshaw | A. Docherty | M. Semple | R. Pius | E. Harrison | L. Turtle | M. Lipman | T. Drake | C. Russell | Rishi K. Gupta | M. Quartagno | S. Knight | A. Ho | G. Carson | C. Fairfield | S. Halpin | H. Hardwick | K. Holden | C. Jackson | K. McLean | L. Norman | M. Pritchard | O. Swann | C. Green | E. Harrison | R. Gupta | C. Sudlow | Christopher A Green | T. Solomon | I. Buchan | S. Knight | Aziz Sheikh | Lisa Norman | K. Mclean | Catherine A Shaw | Matteo Quartagno | Jonathan S Nguyen-Van-Tam
[1] B. Furlow. COVACTA trial raises questions about tocilizumab's benefit in COVID-19 , 2020, The Lancet Rheumatology.
[2] Arthur S Slutsky,et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. , 2020, JAMA.
[3] Keith Sigel,et al. An inflammatory cytokine signature predicts COVID-19 severity and survival , 2020, Nature Medicine.
[4] Jordan J. Clark,et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score , 2020, BMJ.
[5] Mahdad Noursadeghi,et al. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study , 2020, European Respiratory Journal.
[6] Lee-Jen Wei,et al. Remdesivir for the Treatment of Covid-19 - Preliminary Report. , 2020, The New England journal of medicine.
[7] Jennifer L. Bell,et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.
[8] Mike Clarke,et al. A minimal common outcome measure set for COVID-19 clinical research , 2020, The Lancet Infectious Diseases.
[9] P. Horby,et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study , 2020, BMJ.
[10] C. Li,et al. Risk prediction for poor outcome and death in hospital in-patients with COVID-19: derivation in Wuhan, China and external validation in London, UK , 2020, medRxiv.
[11] G. Heinze,et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal , 2020, BMJ.
[12] Richard D Riley,et al. Temporal recalibration for improving prognostic model development and risk predictions in settings where survival is improving over time , 2020, International journal of epidemiology.
[13] Richard D Riley,et al. Calculating the sample size required for developing a clinical prediction model , 2020, BMJ.
[14] Jian Sun,et al. ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan, China , 2020, medRxiv.
[15] Kohske Takahashi,et al. Welcome to the Tidyverse , 2019, J. Open Source Softw..
[16] Andrew J. Vickers,et al. A simple, step-by-step guide to interpreting decision curve analysis , 2019, Diagnostic and Prognostic Research.
[17] Richard D Riley,et al. Minimum sample size for developing a multivariable prediction model: PART II ‐ binary and time‐to‐event outcomes , 2018, Statistics in medicine.
[18] G. Collins,et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies , 2019, Annals of Internal Medicine.
[19] J. Richard,et al. Assessment of clinical criteria for sepsis-was the cart put before the horse? , 2016, Journal of thoracic disease.
[20] Lena Osterhagen,et al. Multiple Imputation For Nonresponse In Surveys , 2016 .
[21] Frank E. Harrell,et al. Prediction models need appropriate internal, internal-external, and external validation. , 2016, Journal of clinical epidemiology.
[22] Johannes B. Reitsma,et al. Individual Participant Data (IPD) Meta-analyses of Diagnostic and Prognostic Modeling Studies: Guidance on Their Use , 2015, PLoS medicine.
[23] G. Collins,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement , 2015, BMJ : British Medical Journal.
[24] Yvonne Vergouwe,et al. Towards better clinical prediction models: seven steps for development and an ABCD for validation. , 2014, European heart journal.
[25] J. Hedlund,et al. Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia , 2014, BMJ Open Respiratory Research.
[26] R. Evans. European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[27] Gary B. Smith,et al. The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. , 2013, Resuscitation.
[28] Stef van Buuren,et al. MICE: Multivariate Imputation by Chained Equations in R , 2011 .
[29] Patrick Royston,et al. Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.
[30] Douglas G Altman,et al. Dichotomizing continuous predictors in multiple regression: a bad idea , 2006, Statistics in medicine.
[31] N. Miyashita,et al. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. , 2006, Internal medicine.
[32] L. Lind,et al. Rapid Emergency Medicine score: a new prognostic tool for in‐hospital mortality in nonsurgical emergency department patients , 2004, Journal of internal medicine.
[33] W. Lim,et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.
[34] C. Subbe,et al. Validation of a modified Early Warning Score in medical admissions. , 2001, QJM : monthly journal of the Association of Physicians.
[35] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.